NYSE:ELVHealthcare
Is Elevance Health (ELV) Trading At A Discount After Strong Q2 And Higher Outlook?
Elevance Health (ELV) is back in focus after reporting strong Q2 2026 results, lifting its full year outlook and highlighting AI driven efficiency gains, along with new leadership for Carelon Behavioral Services.
Over the past year Elevance Health has seen a solid build in momentum, with a 1 year total shareholder return of 31.28% alongside a 12.66% year to date share price return. AI driven efficiency gains and the Carelon leadership change help frame recent moves around the current...